Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-006453
Filing Date
2015-10-08
Accepted
2015-10-08 12:06:46
Documents
2
Period of Report
2015-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2315
2 EX-24 DOCUMENT attachment1.htm EX-24 1638
  Complete submission text file 0000899243-15-006453.txt   5474
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 12097 AUSTIN TX 78711
Business Address PO BOX 12097 AUSTIN TX 78711 512-463-3190
Cancer Prevention & Research Institute of Texas (Reporting) CIK: 0001654747 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 0831
Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 151150341